Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
193,548,280
-
Total 13F shares
-
197,770,450
-
Share change
-
+3,850,577
-
Total reported value
-
$18,729,519,781
-
Put/Call ratio
-
132%
-
Price per share
-
$94.71
-
Number of holders
-
479
-
Value change
-
+$262,927,826
-
Number of buys
-
232
-
Number of sells
-
239
Institutional Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q4 2017
As of 31 Dec 2017,
INCYTE CORP - COMMON STOCK (INCY) was held by
479 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
197,770,450 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Vanguard Group Inc, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, SANDS CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Capital International Investors, Capital World Investors, and BB BIOTECH AG.
This page lists
483
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.